Cytokine

Cytokines ( ) are a broad and loose category of small proteins (~5–25 kDa ) important in cell signaling.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 7 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Cytokines ( ) are a broad and loose category of small proteins (~5–25 kDa ) important in cell signaling. Cytokines are produced by a broad range of cells, including immune cells, as well as endothelial cells, fibroblasts, and various types of connective tissue cells. A single cytokine may be produced by more than one type of cell.

Cytokines are usually too large to cross cell membranes and enter cells. They typically function by interacting with specific cytokine receptors on the surface of target cells. Cytokines include chemokines, interferons, interleukins, lymphokines, and tumour necrosis factors, but generally not hormones or growth factors (despite some overlap in the terminology).

Cytokines are especially important in the immune system, including in immune responses and inflammation. Cytokines modulate the balance between humoral and cell-based immune responses, and they regulate the maturation, growth, and responsiveness of particular cell populations. Some cytokines enhance or inhibit the action of other cytokines in complex ways.

Cytokines are generally released in lower concentrations than hormones. Immune cytokines released by one cell can send signals to the same cell (autocrine signaling), nearby cells (paracrine signaling), and other cells throughout the body (endocrine signaling).

Terminology

The word comes from the ancient Greek language: cyto, from Greek κύτος, kytos, 'cavity, cell' + kines, from Greek κίνησις, kinēsis, 'movement'.

Difference from hormones

Classic hormones circulate in aqueous solution in nanomolar (10 M) concentrations that usually vary by less than one order of magnitude. In contrast, some cytokines (such as IL-6) circulate in picomolar (10 M) concentrations that can increase up to 1,000 times during trauma or infection.

The widespread distribution of cellular sources for cytokines may be a feature that differentiates them from hormones. Virtually all nucleated cells, but especially endo/epithelial cells and resident macrophages (many near the interface with the external environment) are potent producers of IL-1, IL-6, and TNF.

In contrast, classic hormones, such as insulin, are secreted from discrete glands such as the pancreas. The current terminology refers to cytokines as immunomodulating agents. A contributing factor to the difficulty of distinguishing cytokines from hormones is that some immunomodulating effects of cytokines are systemic (i.e., affecting the whole organism) rather than local.

For instance, to accurately utilize hormone terminology, cytokines may be autocrine or paracrine in nature, and chemotaxis, chemokinesis and endocrine as a pyrogen. Essentially, cytokines are not limited to their immunomodulatory status as molecules. s, like JAK-STAT pathways, as illustrated on the left side of the diagram.

Conversely, hormones typically activate different signaling pathways, like G protein-coupled receptors, seen at the top of the figure.

Infections and other immune responses

Cytokines are crucial for fighting off infections and in other immune responses. However, they can become dysregulated and pathological in inflammation, trauma, sepsis, and hemorrhagic stroke.

Embryo development

Cytokines are involved in several developmental processes during embryonic development. Cytokines are released from the blastocyst, and are also expressed in the endometrium, and have critical roles in the stages of zona hatching, and implantation.

Ageing

Dysregulated cytokine secretion in the aged population can lead to inflammaging, and render these individuals more vulnerable to age-related diseases like neurodegenerative diseases and type 2 diabetes.

Narcolepsy and fatigue

A 2024 study found a positive correlation between plasma interleukin IL-2 and fatigue in patients with type 1 narcolepsy.

COVID-19

Autoantibodies against cytokines also plays a role in health and disease. In 2020 neutralizing autoantibodies against type I interferons were reported in 10.2% of patients with life-threatening COVID-19. In a subsequent follow-up study, researchers investigated that the prevalence of autoantibodies against type I interferons increases with age.

Only 0.17% of individuals under 70 years of age tested positive for these autoantibodies, compared with 4.2% among those aged 80 to 85 years. Furthermore, autoantibodies against IFN-α/ω were detected in approximately 20% of patients over 80 years old with critical COVID-19.

ME/CFS

A 2019 review was inconclusive as to whether cytokines play any definitive role in ME/CFS.

Adverse effects

Adverse effects of cytokines have been linked to many disease states and conditions including schizophrenia, major depression, Alzheimer's disease, and cancer.

Tumors

T regulatory cells (Tregs) and related-cytokines are effectively engaged in the process of tumor immune escape and functionally inhibit immune response against the tumor. Forkhead box protein 3 (Foxp3) as a transcription factor is an essential molecular marker of Treg cells.

Foxp3 polymorphism (rs3761548) might be involved in cancer progression like gastric cancer through influencing Tregs function and the secretion of immunomodulatory cytokines such as IL-10, IL-35, and TGF-β. Normal tissue integrity is preserved by feedback interactions between diverse cell types mediated by adhesion molecules and secreted cytokines; disruption of normal feedback mechanisms in cancer threatens tissue integrity.

Cytokine storms

Over-secretion of cytokines can trigger a dangerous cytokine storm syndrome. Cytokine storms may have been the cause of severe adverse events during a clinical trial of TGN1412. Cytokine storms are also suspected to have been the main cause of death in the 1918 "Spanish Flu" pandemic.

Deaths were weighted more heavily towards people with healthy immune systems, because of their ability to produce stronger immune responses, with dramatic increases in cytokine levels. Another example of cytokine storm is seen in acute pancreatitis.

Cytokines are integral and implicated in all angles of the cascade, resulting in the systemic inflammatory response syndrome and multi-organ failure associated with this intra-abdominal catastrophe. In the COVID-19 pandemic, some deaths from COVID-19 have been attributable to cytokine release storms.

Data suggest cytokine storms may be the source of extensive lung tissue damage and dysfunctional coagulation in COVID-19 infections. Prenatal SARS-COV-2 infection in pregnant women is linked to developmental delays with high level of interferon-gamma in cord blood correlated with cognitive delays, while interleukin-6, IL-8, IL-17, and IL-1β were associated with motor delays.

Medical use as drugs

Some cytokines have been developed into protein therapeutics using recombinant DNA technology. Recombinant cytokines being used as drugs as of 2014 include: Bone morphogenetic protein (BMP), used to treat bone-related conditions Erythropoietin (EPO), used to treat anemia Granulocyte colony-stimulating factor (G-CSF), used to treat neutropenia in cancer patients Granulocyte macrophage colony-stimulating factor (GM-CSF), used to treat neutropenia and fungal infections in cancer patients Interferon alfa, used to treat hepatitis C and multiple sclerosis Interferon beta, used to treat multiple sclerosis Interleukin 2 (IL-2), used to treat cancer.

Interleukin 11 (IL-11), used to treat thrombocytopenia in cancer patients. Interferon gamma is used to treat chronic granulomatous disease and osteopetrosis

Cytokine Signalling Forum Cytokine Tutorial Cytokine Gene Summary, Ontology, Pathways and More: Immunology Database and Analysis Portal (ImmPort)

Text derived from https://en.wikipedia.org/w/index.php?oldid=1375131652 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

8 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.